He could not have expected that the Review would prove such an influential vehicle for the Chesterton revival during the following decades, nor could he have expected or imagined that the Review ...
Il blog dell'Uomo Vivo
-
13-5-2024
|
|
|
The Company continued to attract top talent following the onboarding of Steve Choate as the Company's new Chief Operating Officer on April 8, 2024. Mr. Choate's extensive experience and expertise as ...
01Net
-
11-5-2024
|
|
|
This in - depth survey and recognition program analyzes employers' policies, practices, and outcomes in detail, across the following 5 categories: Veteran job candidate recruiting and hiring Veteran ...
01Net
-
10-5-2024
|
|
|
The Company is providing the following revised outlook for the fiscal year ending September 30, 2024: (in thousands, except share and per share amounts) Previous Outlook Range Revised Outlook Range ...
01Net
-
10-5-2024
|
|
|
A 30 - day online replay will be available approximately one hour following the conclusion of the live webcast. To listen to the live webcast or access the replay, visit the Company's investor ...
01Net
-
10-5-2024
|
|
|
|
Houthis began firing missiles and drones at merchant ships in the Red Sea after Israel started its devastating war against Hamas in Gaza following the Palestinian Islamist group's 7 October cross - ...
Adnkronos
-
10-5-2024
|
|
|
ATLANTA-(BUSINESS WIRE)-Corpay, Inc., (NYSE: CPAY) a global leader in corporate payments, today announced that the Company will participate in the following investor conferences: On Wednesday, May 15, 2024, Tom Panther, Chief Financial Officer, and Jim Eglseder, SVP, Global Investor Relations, will be attending the Barclays Annual Emerging ...
01Net
-
10-5-2024
|
|
|
Three Months Ended March 31, 2024 Total operating expenses $ 142.2 Adjusted to exclude the following: Stellantis warrant expense (1) (2.1) Stock - based compensation (2) (40.7) Technology and dispute ...
01Net
-
10-5-2024
|
|
|
'Following the initial FDA clearance for AIMIGo, we plan to submit a second 510(k) application in Q3 2024. This submission will include results from our pivotal VALID - ECG clinical study. To date, ...
01Net
-
10-5-2024
|
|
|
To access the call, please use the following information: Date: Thursday, May 9, 2024 Time: 4:30 p.m. Eastern Time,
01Net
-
10-5-2024
|
|
|